Gene · 5598
Papers3,971
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
321 to 340 of 3,971
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The Fe-S cluster assembly protein IscU2 increases α-ketoglutarate catabolism and DNA 5mC to promote tumor growth. | Cell Discov | 2023 | 37488138 | PubTator, text mining | PubMed |
| The potential of activator protein 1 (AP-1) in cancer targeted therapy. | Front Immunol | 2023 | 37483616 | PubTator, text mining | PubMed |
| Revealing the role of nitroxyl during hepatic ischemia-reperfusion injury with a NIR-II luminescent nanoprobe. | Chem Sci | 2023 | 37476722 | PubTator, text mining | PubMed |
| Metronomic Administration of Topotecan Alone and in Combination with Docetaxel Inhibits Epithelial-mesenchymal Transition in Aggressive Variant Prostate Cancers. | Cancer Res Commun | 2023 | 37476073 | PubTator, text mining | PubMed |
| Application and Resistance Mechanisms of Lenvatinib in Patients with Advanced Hepatocellular Carcinoma. | J Hepatocell Carcinoma | 2023 | 37457652 | PubTator, text mining | PubMed |
| Wound healing effects of Asparagus lucidus Lindl extract through the phosphorylation of ERK1/2. | BMC Complement Med Ther | 2023 | 37454069 | PubTator, text mining | PubMed |
| Orchestrating smart therapeutics to achieve optimal treatment in small cell lung cancer: recent progress and future directions. | J Transl Med | 2023 | 37452395 | PubTator, text mining | PubMed |
| Involvement of the p38/MK2 Pathway in MCLR Hepatotoxicity Revealed through MAPK Pharmacological Inhibition and Phosphoproteomics in HepaRG Cells. | Int J Mol Sci | 2023 | 37446360 | PubTator, text mining | PubMed |
| The Impact of Hydroxychloroquine on Primary Feto-Placental Endothelial Cells from Healthy and Early-Onset Preeclamptic Placentas. | Int J Mol Sci | 2023 | 37446111 | PubTator, text mining | PubMed |
| The Microenvironment of the Pathogenesis of Cardiac Hypertrophy. | Cells | 2023 | 37443814 | PubTator, text mining | PubMed |
| Microvascular Thrombosis and Liver Fibrosis Progression: Mechanisms and Clinical Applications. | Cells | 2023 | 37443746 | PubTator, text mining | PubMed |
| Targeting signaling pathways in osteosarcoma: Mechanisms and clinical studies. | MedComm (2020) | 2023 | 37441462 | PubTator, text mining | PubMed |
| The role of the ERK signaling pathway in promoting angiogenesis for treating ischemic diseases. | Front Cell Dev Biol | 2023 | 37427386 | PubTator, text mining | PubMed |
| A multi-omics integrative approach unravels novel genes and pathways associated with senescence escape after targeted therapy in NRAS mutant melanoma. | Cancer Gene Ther | 2023 | 37420093 | PubTator, text mining | PubMed |
| Functional Analysis and Clinical Importance of ATP1A1 in Colon Cancer. | Ann Surg Oncol | 2023 | 37407874 | PubTator, text mining | PubMed |
| The role of lysosomal peptidases in glioma immune escape: underlying mechanisms and therapeutic strategies. | Front Immunol | 2023 | 37398678 | PubTator, text mining | PubMed |
| Maternal obesity alters the placental transcriptome in a fetal sex-dependent manner. | Front Cell Dev Biol | 2023 | 37397247 | PubTator, text mining | PubMed |
| Sphingosine 1-phosphate elicits a ROS-mediated proinflammatory response in human endometrial stromal cells via ERK5 activation. | FASEB J | 2023 | 37389926 | PubTator, text mining | PubMed |
| Conjugation, Prodrug, and Co-Administration Strategies in Support of Nanotechnologies to Improve the Therapeutic Efficacy of Phytochemicals in the Central Nervous System. | Pharmaceutics | 2023 | 37376027 | PubTator, text mining | PubMed |
| 360-Degree Perspectives on Obesity. | Medicina (Kaunas) | 2023 | 37374323 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5598/papers?page=17